The Clorox Company $CLX Holdings Reduced by Zullo Investment Group Inc.

Zullo Investment Group Inc. decreased its position in The Clorox Company (NYSE:CLX) by 9.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,708 shares of the company’s stock after selling 277 shares during the period. Zullo Investment Group Inc.’s holdings in Clorox were worth $325,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Mengis Capital Management Inc. grew its position in Clorox by 119.5% in the 2nd quarter. Mengis Capital Management Inc. now owns 14,443 shares of the company’s stock worth $1,734,000 after purchasing an additional 7,864 shares during the last quarter. Commerzbank Aktiengesellschaft FI bought a new position in Clorox in the 2nd quarter worth about $255,000. IFP Advisors Inc grew its position in Clorox by 8.8% in the 2nd quarter. IFP Advisors Inc now owns 5,289 shares of the company’s stock worth $635,000 after purchasing an additional 428 shares during the last quarter. Callan Family Office LLC acquired a new stake in shares of Clorox in the 2nd quarter worth approximately $317,000. Finally, Leo Wealth LLC acquired a new stake in shares of Clorox in the 2nd quarter worth approximately $285,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.1%

CLX stock opened at $120.14 on Friday. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37. The firm has a market cap of $14.63 billion, a PE ratio of 18.43, a P/E/G ratio of 0.98 and a beta of 0.52. The firm has a 50 day simple moving average of $122.21 and a 200 day simple moving average of $128.79. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period in the prior year, the business earned $1.82 earnings per share. The business’s quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a research note on Friday. The Goldman Sachs Group reduced their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. UBS Group reduced their price target on shares of Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a research note on Wednesday. Bank of America reduced their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday. Finally, Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research note on Monday, September 29th. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Reduce” and an average target price of $131.92.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.